MGMT and glioblastoma: Pavan Nathani et al. (November 2024) presented a radiogenomic model for predicting Methylguanine DNA Methyltransferase (MGMT) promoter hypermethylation in Glioblastoma Multiforme (GBM) using multimodal MRI data and the EfficientNet deep learning architecture [16].